LD-2 disclosure · 2nd Quarter - Report
THE PROCTER AND GAMBLE COMPANY
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Manufacturing
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
8 issuesPharmacy
-Issues related to FDA review of active ingredients in over-the-counter products
LobbyistsCHRISTINA LOTSPIKE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP)
Health Issues
-Issues related to Generally Recognized as Safe (GRAS) and Additive Ingredients Regulation -H.R. 1219, Oral Health Products Inclusion Act -Issues related to New Approach Methodologies (NAMs) non-animal technologies used to evaluate drug safety and efficacy
LobbyistsCHRISTINA LOTSPIKE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
-Section 232 Steel/Aluminum Trade Investigation -Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 122 Balance of Payment Tariffs -Section 301 Excess Capacity/Forced Labor Investigations -Medical Devices/PPE Section 232 Investigation -U.S.-China Board of Trade -Industrial Machinery Section 232 Investigation -Issues related to counterfeit products/illicit trade
Lobbyistsmrs TARA HOGAN CHARLES · ROBERT CUSMANO · NICOLE C COLLIER · CHRISTINA LOTSPIKE